The elderly care industry chain mainly includes the following seven aspects:
1. Elderly care, including: elderly rehabilitation medicine, health care, health care, etc.
2. Supplies for the elderly, including mobility scooters, mobile phones for the elderly, hearing aids, etc.
3. Elderly services, including daily meals, pension insurance and psychological counseling.
4. Retirement real estate, including retirement apartments and retirement communities.
5. Elderly culture, including the education and spiritual and cultural life of the elderly.
6. Travel for the elderly, including senior tourism.
7. Catering for the elderly.
How to use technological progress and industrial development to support healthy aging
Coping with aging requires not only strengthening the construction of medical and health care systems, but also technological progress and industrial support. This is Solving the shortage of service human resources in the context of aging and improving service efficiency and service quality are important means that have become a common direction of efforts in aging countries. The health and elderly care industry involves many contents. This study mainly focuses on industries such as pharmaceutical products, health insurance, smart medical care, aging-friendly infrastructure transformation, and assistive devices. These are key areas for improving the health and quality of life of the elderly. China's related industries already have a certain development foundation, but compared with the needs of an aging population and compared with the levels of advanced countries, the gap is still very large. In the coming period, it is necessary to learn from international experience, improve the industrial policy system, and accelerate development.
1. Improve supply and security levels to meet the growing demand for elderly pharmaceutical products and services
1. The problem of insufficient medication and treatment for elderly diseases is very prominent
Based on the existing disease spectrum and its changing patterns, the prevalence of tumors among the elderly in China will continue to rise, the prevalence and mortality of cardiovascular and cerebrovascular diseases will remain high, and new diseases such as Alzheimer's disease and rare diseases will continue to rise. The disease burden is rising, new infection risks and problems cannot be ignored, and diseases that cause disability and affect the ability to live independently need to be paid attention to. Judging from these clinical needs, the accessibility of drugs and treatments for the elderly is still insufficient. The main problems are as follows:
●For Alzheimer's disease and some rare diseases, no effective drugs and treatments have been developed internationally so far;
●For some malignant diseases, Although there are drugs and treatments for tumors, they are not effective enough;
●For some diseases, more effective drugs have been developed internationally, but the prices are high and the burden on patients is heavy. For example, for some tumors Targeted drugs and biological products;
●For chronic obstructive pulmonary disease, diabetes, etc., drug administration routes and mechanisms of action need to be optimized, and convenience and safety need to be improved;
●Due to differences in disease spectrum, there is insufficient research and development of drugs and treatments for some China-specific high-incidence diseases such as liver cancer, esophageal cancer, and gastric cancer.
●There is a shortage of preventive products such as vaccines against various infections, early diagnostic products such as various reagents, functional restoration products such as artificial hip joints and other consumables, and quality-of-life-improving drugs such as pain management. , low quality and high price.
Figure 1 The status of meeting the clinical needs of diseases and the contribution of drugs in China
2. Several issues that need to be solved to improve the accessibility of drugs and treatments for the elderly
●Encourage innovation and strengthen the research and development of new drugs and technical means in key areas. Comprehensive use of tax and financial support measures will strengthen incentives for corporate innovation; strengthen intellectual property and patent protection, and increase penalties for infringements; combined with changes in the needs of the elderly for diseases, identify key areas and formulate a clearer pharmaceutical industry development strategy. Promote the in-depth integration of industry, academia and research in the pharmaceutical field and accelerate the transformation of results. Further improve the relevant policy system and encourage in-depth cooperation between Chinese and foreign enterprises and research institutions in the field of pharmaceutical research and development.
●Further improve the review and approval system and accelerate the introduction of innovative drugs and new treatments. In the construction of special channels for drug approval, more consideration will be given to the drugs and treatments urgently needed by the elderly. Actively summarize the relevant experience of the Boao Lecheng International Medical Tourism Pilot Zone and promote it in a timely manner.
●Improve the policy on generic drugs. While further strengthening the protection of patented drugs, we should improve policies to support the research and development of generic drugs and speed up the replacement of original drugs with expired patents by generic drugs; increase the industrial concentration of generic drug companies, standardize the order of market competition, and further strengthen supervision and consistency. evaluation to ensure the quality of generic drugs.